Sana Biotechnology, Inc.
SANA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001770121
No open-market purchases or sales by Sana Biotechnology, Inc. insiders were filed in the last 90 days; 211 institutions reported holding it in 13F filings for Q2 2026, worth $644.7M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Sana Biotechnology, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 125 | 1 | 120 | −4 |
| Shares | 128.3M | 28.7K | 128.4M | +90.8K (+0.1%) |
| Value | $769.7M | $172.0K | $507.0M | −$262.5M (−34.1%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Sana Biotechnology, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Federated Hermes, Inc. | 260,900 | $1.03M | 0.00% |
| Capula Management Ltd | 152,990 | $604.3K | 0.06% |
| XTX Topco Ltd | 85,143 | $336.3K | 0.07% |
| CI Private Wealth, LLC | 78,678 | $310.8K | 0.00% |
| Landscape Capital Management, L.L.C. | 24,433 | $96.5K | 0.01% |
| Aquatic Capital Management LLC | 10,500 | $40.0K | 0.00% |
| Point72 Middle East FZE | 9,379 | $37.0K | 0.00% |
| Lazard Asset Management LLC | 2,642 | $10.0K | 0.00% |
| Belpointe Asset Management LLC | 2,185 | $8.63K | 0.00% |
| Northwest Investment Counselors, LLC | 750 | $2.96K | 0.00% |
| Signaturefd, LLC | 690 | $2.73K | 0.00% |
| Advisor Group Holdings, Inc. | 265 | $1.00K | 0.00% |
| Allworth Financial LP | 41 | $162 | 0.00% |
Sold out (17)
Institutions that held Sana Biotechnology, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| LMR Partners LLP | 300,000 | $1.80M |
| BNP Paribas Arbitrage, SA | 225,732 | $1.35M |
| Schonfeld Strategic Advisors LLC | 134,854 | $809.0K |
| Trexquant Investment LP | 95,550 | $573.0K |
| HRT Financial LP | 67,970 | $407.0K |
| Boulder Hill Capital Management LP | 51,500 | $309.0K |
| Occudo Quantitative Strategies LP | 48,411 | $290.0K |
| Jane Street Group, LLC | 39,347 | $236.0K |
| Marshall Wace, LLP | 29,180 | $175.0K |
| Dynamic Technology Lab Private Ltd | 21,778 | $131.0K |
| Quantamental Technologies LLC | 11,585 | $70.0K |
| Bridgefront Capital, LLC | 10,475 | $63.0K |
| Point72 Hong Kong Ltd | 9,733 | $58.0K |
| Global Trust Asset Management, LLC | 298 | $2.00K |
| Beaird Harris Wealth Management, LLC | 276 | $2.00K |
| First Manhattan Co | 200 | $1.00K |
| Lindbrook Capital, LLC | 234 | $1.00K |
Not filed for Q4 2022 yet (1)
Institutions that held Sana Biotechnology, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| CPWM, LLC | 28,678 | $172.0K |